PreDx receives €7.7M EU Horizon grant for FluiDx-AD project.

The FluiDx-AD project, funded by the European Union’s Horizon Europe programme with a budget of EUR 7,699,219.38 for three and a half years, aims to improve the early diagnosis and management of Alzheimer’s disease (AD). The project is scientifically led by Dr Erik Christensen MD PhD, Co-founder and CMO at Pre Diagnostics AS. Coordinated by Oslo University Hospital, represented by Dr Ira Ronit Hebold Haraldsen MD PhD, the project brings together a consortium of ten partners across Europe.

Receives EU funding for development of groundbreaking Alzheimer's tests - Norway Health Tech